5AM Partners VI, LLC - 11 Jan 2022 Form 4 Insider Report for CinCor Pharma, Inc.

Role: 10%+ Owner
Signature: 5AM Partners VI, LLC, By /s/ Kush Parmar, Managing Member
Issuer symbol: N/A
Transactions as of: 11 Jan 2022
Net transactions value: +$7,520,000
Form type: 4
Filing time: 13 Jan 2022, 15:45:33 UTC
Previous filing: 06 Jan 2022
Next filing: 17 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CINC	Common Stock	Conversion of derivative security		+3,683,823			3,683,823	11 Jan 2022	By 5AM Ventures VI, L.P.	F1, F2
transaction	CINC	Common Stock	Conversion of derivative security		+183,823			183,823	11 Jan 2022	By 5AM Opportunities I, L.P.	F1, F3
transaction	CINC	Common Stock	Purchase	$2,520,000	+157,500	+4.3%	$16.00	3,841,323	11 Jan 2022	By 5AM Ventures VI, L.P.	F2
transaction	CINC	Common Stock	Purchase	$5,000,000	+312,500	+170%	$16.00	496,323	11 Jan 2022	By 5AM Opportunities I, L.P.	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CINC	Series A Preferred Stock	Conversion of derivative security	$0	-9,999,999	-100%	$0.000000^*	0	11 Jan 2022	Common Stock	2,941,176		By 5AM Ventures VI, L.P.	F1, F2
transaction	CINC	Series B Preferred Stock	Conversion of derivative security	$0	-2,525,000	-100%	$0.000000^*	0	11 Jan 2022	Common Stock	742,647		By 5AM Ventures VI, L.P.	F1, F2
transaction	CINC	Series B Preferred Stock	Conversion of derivative security	$0	-625,000	-100%	$0.000000^*	0	11 Jan 2022	Common Stock	183,823		By 5AM Opportunities I, L.P.	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO") for no additional consideration, on a 3.4:1 basis, and had no expiration date.
F2	The shares are directly held by 5AM Ventures VI, L.P. ("Ventures VI"). 5AM Partners VI, LLC ("Partners VI") is the sole general partner of Ventures VI. Dr. Kush Parmar and Andrew J. Schwab are the managing members of Partners VI and may be deemed to have shared voting and investment power over the shares beneficially owned by Ventures VI. Each of Partners VI, Dr. Parmar, and Mr. Schwab disclaims beneficial ownership of such shares except to the extent of its or his pecuniary interest therein.
F3	Shares are held by 5AM Opportunities I, L.P. ("Opportunities"). 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are the managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP, Mr. Schwab and Dr. Parmar disclaims beneficial ownership of such shares except to the extent of its or his pecuniary interest therein.